The Valley Desk

NCT03543813 · Interventional trial

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Overall registry status Completed

Phase 1 · Phase 2

Conditions Diffuse Large B Cell Lymphoma, Esophageal Cancer, Head and Neck Cancer, Non Small Cell Lung Cancer, Solid Tumor, Adult

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov